My time is currently divided between pre-clinical medical research and industry-academia collaborations to support the Welsh Bioscience industry through the Avenues for Commercialisation of Nano- and Micro-technologies (ACNM) grant. My interests lie in gynaecological cancer biology, cancer therapeutics and therapy resistance. I am also interested in the use of targeted drug delivery systems to increase tumour uptake and to reduce the systemic toxicities associated with administration of free-drugs. Together with colleagues in the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School, I am exploring the use of high-content imaging and phenotypic feature extraction for evaluating the influence of therapeutics and therapeutic combinations on cell phenotypes of tumour cells to provide insight into drug mechanisms . These techniques also being applied to the evaluation of drug delivery systems under development by RBGO.